Delivery Order SPE2DR25D1052-SPE2DR26F6BX0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,264.48 to AmerisourceBergen Drug Corp for 90 capsules of Nexium DR 40 mg on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Nexium DR 20 mg capsules (90-count units) with a contract ceiling value of $1,194.51. This is a firm fixed price delivery order with an ultimate completion date of September 25, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Nexium DR 40 mg capsules (30-count units) with a ceiling value of $2,323.45. This firm fixed price delivery order, with an ultimate completion date of August 18, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award was made through competitive procurement with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.18 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- This delivery order, issued on October 23, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,125.04 for the supply of NEXIUM DR 40 mg capsules (90-count packages) to support federal pharmaceutical procurement needs. The contract is expected to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded order placed through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,267.54 for 90 capsules of Nexium DR 40 mg on October 28, 2025, with completion targeted for October 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,804.10 on July 22, 2025, for the supply of Nexium DR 20 mg capsules (30-count packages). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nexium DR 20 mg capsules (30-count units) with a ceiling value of $1,687.86. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award of this pharmaceutical supply requirement. The contract is set to complete by September 26, 2025, with performance fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6BX0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of NEXIUM DR 40 mg capsules (90-count units) at a ceiling value of $3,460.38. This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by November 5, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal government healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability in meeting federal procurement requirements through competitive contracting, with a portfolio spanning specialty medications, brand-name and generic drugs, and various medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/4/25 |